Stay updated with breaking news from Pascal Deschatelets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its price objective upped by stock analysts at Bank of America from $112.00 to $114.00 in a research note issued to investors on Friday, The Fly reports. Bank of America‘s price target indicates a potential upside of 35.12% from the stock’s current price. Several other brokerages have also […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its price objective hoisted by Wells Fargo & Company from $55.00 to $76.00 in a research note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s target price would suggest a potential downside of 9.92% from the company’s previous close. Several other equities analysts also […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s share price traded down 6.1% during mid-day trading on Thursday . The stock traded as low as $78.14 and last traded at $79.55. 898,539 shares changed hands during trading, a decline of 47% from the average session volume of 1,702,431 shares. The stock had previously closed at $84.68. […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) shares traded down 6.1% on Thursday . The company traded as low as $78.14 and last traded at $79.55. 898,539 shares were traded during trading, a decline of 47% from the average session volume of 1,702,431 shares. The stock had previously closed at $84.68. Analyst Upgrades and Downgrades […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $88.51 and last traded at $88.27, with a volume of 1040253 shares traded. The stock had previously closed at $86.25. Analyst Ratings Changes A number of research analysts have […]